Answer
Yes, bullous pemphigoid has been reported after marketing in patients taking DPP-4 inhibitors including alogliptin, and alogliptin should be discontinued if bullous pemphigoid is suspected.
Sources for this answer
- Alogliptin 6.25 mg film-coated tabletsTakeda UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked